Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 234

1.

Menin molecular interactions: insights into normal functions and tumorigenesis.

Agarwal SK, Kennedy PA, Scacheri PC, Novotny EA, Hickman AB, Cerrato A, Rice TS, Moore JB, Rao S, Ji Y, Mateo C, Libutti SK, Oliver B, Chandrasekharappa SC, Burns AL, Collins FS, Spiegel AM, Marx SJ.

Horm Metab Res. 2005 Jun;37(6):369-74. Review.

PMID:
16001329
2.

Mechanisms of disease: multiple endocrine neoplasia type 1-relation to chromatin modifications and transcription regulation.

Dreijerink KM, Höppener JW, Timmers HM, Lips CJ.

Nat Clin Pract Endocrinol Metab. 2006 Oct;2(10):562-70. Review.

PMID:
17024155
3.

MEN1 in pancreatic endocrine tumors: analysis of gene and protein status in 169 sporadic neoplasms reveals alterations in the vast majority of cases.

Corbo V, Dalai I, Scardoni M, Barbi S, Beghelli S, Bersani S, Albarello L, Doglioni C, Schott C, Capelli P, Chilosi M, Boninsegna L, Becker KF, Falconi M, Scarpa A.

Endocr Relat Cancer. 2010 Aug 16;17(3):771-83. doi: 10.1677/ERC-10-0028. Print 2010 Sep.

4.

Menin promotes the Wnt signaling pathway in pancreatic endocrine cells.

Chen G, A J, Wang M, Farley S, Lee LY, Lee LC, Sawicki MP.

Mol Cancer Res. 2008 Dec;6(12):1894-907. doi: 10.1158/1541-7786.MCR-07-2206.

5.

The gene for multiple endocrine neoplasia type 1: recent findings.

Marx SJ, Agarwal SK, Heppner C, Kim YS, Kester MB, Goldsmith PK, Skarulis MC, Spiegel AM, Burns AL, Debelenko LV, Zhuang Z, Lubensky IA, Liotta LA, Emmert-Buck MR, Guru SC, Manickam P, Crabtree JS, Collins FS, Chandrasekharappa SC.

Bone. 1999 Jul;25(1):119-22. Review.

PMID:
10423035
6.

Functional studies of the MEN1 gene.

Chandrasekharappa SC, Teh BT.

J Intern Med. 2003 Jun;253(6):606-15.

7.

Multiple endocrine neoplasia type 1: clinical and genetic features of the hereditary endocrine neoplasias.

Marx SJ, Agarwal SK, Kester MB, Heppner C, Kim YS, Skarulis MC, James LA, Goldsmith PK, Saggar SK, Park SY, Spiegel AM, Burns AL, Debelenko LV, Zhuang Z, Lubensky IA, Liotta LA, Emmert-Buck MR, Guru SC, Manickam P, Crabtree J, Erdos MR, Collins FS, Chandrasekharappa SC.

Recent Prog Horm Res. 1999;54:397-438; discussion 438-9. Review.

PMID:
10548885
8.

Reconstituted expression of menin in Men1-deficient mouse Leydig tumour cells induces cell cycle arrest and apoptosis.

Hussein N, Casse H, Fontanière S, Morera AM, Asensio MJ, Bakeli S, Lu JL, Coste I, Di Clemente N, Bertolino P, Zhang CX.

Eur J Cancer. 2007 Jan;43(2):402-14. Epub 2006 Dec 20.

PMID:
17184987
9.

Germline mutation profile of MEN1 in multiple endocrine neoplasia type 1: search for correlation between phenotype and the functional domains of the MEN1 protein.

Wautot V, Vercherat C, Lespinasse J, Chambe B, Lenoir GM, Zhang CX, Porchet N, Cordier M, Béroud C, Calender A.

Hum Mutat. 2002 Jul;20(1):35-47.

PMID:
12112656
10.

Ribozyme-mediated compensatory induction of menin-oncosuppressor function in primary fibroblasts from MEN1 patients.

Luzi E, Marini F, Tognarini I, Carbonell Sala S, Galli G, Falchetti A, Brandi ML.

Cancer Gene Ther. 2010 Nov;17(11):814-25. doi: 10.1038/cgt.2010.39. Epub 2010 Aug 13.

PMID:
20706287
11.

Menin interacting proteins as clues toward the understanding of multiple endocrine neoplasia type 1.

Poisson A, Zablewska B, Gaudray P.

Cancer Lett. 2003 Jan 10;189(1):1-10. Review.

PMID:
12445671
12.

MEN1 tumor-suppressor protein localizes to telomeres during meiosis.

Suphapeetiporn K, Greally JM, Walpita D, Ashley T, Bale AE.

Genes Chromosomes Cancer. 2002 Sep;35(1):81-5.

PMID:
12203793
13.

Menin and its interacting proteins: elucidation of menin function.

Balogh K, Rácz K, Patócs A, Hunyady L.

Trends Endocrinol Metab. 2006 Nov;17(9):357-64. Epub 2006 Sep 25. Review.

PMID:
16997566
14.

MEN1 missense mutations impair sensitization to apoptosis induced by wild-type menin in endocrine pancreatic tumor cells.

Bazzi W, Renon M, Vercherat C, Hamze Z, Lacheretz-Bernigaud A, Wang H, Blanc M, Roche C, Calender A, Chayvialle JA, Scoazec JY, Cordier-Bussat M.

Gastroenterology. 2008 Nov;135(5):1698-1709.e2. doi: 10.1053/j.gastro.2008.07.031. Epub 2008 Jul 31.

PMID:
18775714
15.

Multiple endocrine neoplasia type 1: a chromatin writer's block.

Dreijerink KM, Lips CJ, Timmers HT.

J Intern Med. 2009 Jul;266(1):53-9. doi: 10.1111/j.1365-2796.2009.02115.x. Review.

16.

Molecular pathology of the MEN1 gene.

Agarwal SK, Lee Burns A, Sukhodolets KE, Kennedy PA, Obungu VH, Hickman AB, Mullendore ME, Whitten I, Skarulis MC, Simonds WF, Mateo C, Crabtree JS, Scacheri PC, Ji Y, Novotny EA, Garrett-Beal L, Ward JM, Libutti SK, Richard Alexander H, Cerrato A, Parisi MJ, Santa Anna-A S, Oliver B, Chandrasekharappa SC, Collins FS, Spiegel AM, Marx SJ.

Ann N Y Acad Sci. 2004 Apr;1014:189-98. Review.

PMID:
15153434
17.

Stable overexpression of MEN1 suppresses tumorigenicity of RAS.

Kim YS, Burns AL, Goldsmith PK, Heppner C, Park SY, Chandrasekharappa SC, Collins FS, Spiegel AM, Marx SJ.

Oncogene. 1999 Oct 21;18(43):5936-42.

18.

Differential expression of menin in various adrenal tumors. The role of menin in adrenal tumors.

Bhuiyan MM, Sato M, Murao K, Imachi H, Namihira H, Ishida T, Takahara J, Miyauchi A.

Cancer. 2001 Sep 15;92(6):1393-401.

PMID:
11745215
19.

Menin, a gene product responsible for multiple endocrine neoplasia type 1, interacts with the putative tumor metastasis suppressor nm23.

Ohkura N, Kishi M, Tsukada T, Yamaguchi K.

Biochem Biophys Res Commun. 2001 Apr 20;282(5):1206-10.

PMID:
11302744
20.

Increased menin expression in sporadic pituitary adenomas.

Wrocklage C, Gold H, Hackl W, Buchfelder M, Fahlbusch R, Paulus W.

Clin Endocrinol (Oxf). 2002 May;56(5):589-94.

PMID:
12030908

Supplemental Content

Support Center